Athira Pharma Inc.

16.59+0.1400+0.85%Vol 211.40K1Y Perf -2.57%
Apr 16th, 2021 16:00 DELAYED
BID15.65 ASK16.94
Open16.41 Previous Close16.45
Pre-Market- After-Market-
 - -  - -%
Target Price
42.33 
Analyst Rating
— — 0.00
Potential %
155.15 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap615.82M 
Earnings Rating
Price Range Ratio 52W %
4.21 
Earnings Date
25th Mar 2021

Today's Price Range

16.0216.83

52W Range

15.7934.79

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-13.05%
1 Month
-19.70%
3 Months
-37.51%
6 Months
-9.39%
1 Year
-2.57%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
ATHA16.590.14000.85
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.29-0.2417.24
Q03 2020-0.25-1.12-348.00
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-0.29
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume211.40K
Shares Outstanding37.12M
Trades Count2.92K
Dollar Volume9.31M
Avg. Volume394.99K
Avg. Weekly Volume278.22K
Avg. Monthly Volume276.26K
Avg. Quarterly Volume427.35K

Athira Pharma Inc. (NASDAQ: ATHA) stock closed at 16.59 per share at the end of the most recent trading day (a 0.85% change compared to the prior day closing price) with a volume of 211.78K shares and market capitalization of 615.82M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 15 people. Athira Pharma Inc. CEO is Leen Kawas.

The one-year performance of Athira Pharma Inc. stock is -2.57%, while year-to-date (YTD) performance is -51.56%. ATHA stock has a five-year performance of %. Its 52-week range is between 15.79 and 34.79, which gives ATHA stock a 52-week price range ratio of 4.21%

Athira Pharma Inc. currently has a PE ratio of -11.20, a price-to-book (PB) ratio of 2.52, a price-to-sale (PS) ratio of -, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -14.16%, a ROC of -4.88% and a ROE of -15.68%. The company’s profit margin is -%, its EBITDA margin is -%, and its revenue ttm is $0.00 , which makes it $0.00 revenue per share.

Of the last four earnings reports from Athira Pharma Inc., there were 1 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.29 for the next earnings report. Athira Pharma Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Athira Pharma Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Athira Pharma Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Athira Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Athira Pharma Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 11.21, ATR14 : 1.81, CCI20 : -143.26, Chaikin Money Flow : -0.28, MACD : -1.65, Money Flow Index : 43.41, ROC : -1.83, RSI : 35.98, STOCH (14,3) : 16.43, STOCH RSI : 0.17, UO : 33.12, Williams %R : -83.57), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Athira Pharma Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Athira Pharma Inc.

Athira Pharma Inc is a bio-technology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.

CEO: Leen Kawas

Telephone: +1 206 221-8112

Address: 4000 Mason Road, Seattle 98195, WA, US

Number of employees: 15

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

Bearish Bullish

56%44%

News

Stocktwits